David Michael Clark - 02 Jan 2023 Form 4 Insider Report for AMICUS THERAPEUTICS, INC. (FOLD)

Role: Chief People Officer
Signature: /s/ Christian Formica, Attorney-in-Fact
Issuer symbol: FOLD
Transactions as of: 02 Jan 2023
Net transactions value: -$309,902
Form type: 4
Filing time: 04 Jan 2023, 18:21:17 UTC
Previous filing: 11 Oct 2022
Next filing: 06 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FOLD	Common Stock	Tax liability	$138,413	-11,336	-5.4%	$12.21	198,696	02 Jan 2023	Direct
transaction	FOLD	Common Stock	Sale	$102,176	-8,493	-4.3%	$12.03	190,203	03 Jan 2023	Direct	F1, F2
transaction	FOLD	Common Stock	Award	$0	+59,372	+31%	$0.000000	249,575	03 Jan 2023	Direct	F3
transaction	FOLD	Common Stock	Tax liability	$69,313	-5,810	-2.3%	$11.93	243,765	03 Jan 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FOLD	Stock Options (right to buy)	Award	$0	+105,388		$0.000000	105,388	03 Jan 2023	Common Stock	105,388	$11.93	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale of common stock was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2	This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $11.82 to $12.24. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3	Granted in the form of Restricted Stock Units ("RSUs"), these RSUs will vest in four equal annual installments beginning on January 3, 2024 and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock.
F4	These options vest and become exercisable in a series of installments over a four year period with 25% vesting one year after the date of grant and the remaining 75% vesting ratably each month thereafter.